Financhill
Back

Apellis Pharmaceuticals Vs. Hims & Hers Health Industry Stock Comparison

Sell
27

APLS
Apellis Pharmaceuticals

Last Price:
$18.98
Seasonality Move:
-16.64%
Buy
51

HIMS
Hims & Hers Health

Last Price:
$50.83
Seasonality Move:
-9.01%
Sell
27
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.89. The Score for APLS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Hims & Hers Health (HIMS) is a Buy

Is Hims & Hers Health a Buy, Sell or Hold?

  • The current Hims & Hers Health [HIMS] share price is $48.96. The Score for HIMS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • HIMS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

HIMS Stock Price Chart

What is Hims & Hers Health's stock price today?

  • The Hims & Hers Health share price today is $48.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HIMS is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 47.87 Sell
Chaikin Money Flow: 1240688 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.7 - 19.08) Sell
Bollinger Bands (100): (17.15 - 24.53) Sell

HIMS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.91 Buy
Relative Strength Index (14 RSI): 47.29 Sell
Chaikin Money Flow: -14556369 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.52 - 58.56) Sell
Bollinger Bands (100): (31.74 - 56.26) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.8 Buy
20-day SMA: 18.24 Sell
50-day SMA: 18.15 Sell
200-day SMA: 25.68 Sell
8-day EMA: 17.86 Buy
20-day EMA: 18.04 Sell
50-day EMA: 18.76 Sell
200-day EMA: 26.03 Sell

HIMS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.29 Buy
20-day SMA: 51.96 Sell
50-day SMA: 51.43 Sell
200-day SMA: 34.77 Buy
8-day EMA: 10.88 Buy
20-day EMA: 4.66 Buy
50-day EMA: 1.92 Buy
200-day EMA: 0.49 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.24 per share, and an increase next year of $0.74 per share.

Hims & Hers Health Earnings Growth & HIMS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.10 per share, an increase this year of $0.19 per share, and an increase next year of $0.34 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Hims & Hers Health Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):